Evidence map›Paper›PMID 28902135›Full record

ArticleAntibiotics (Basel, Switzerland)2017

Point Prevalence Surveys of Antimicrobial Use among Hospitalized Children in Six Hospitals in India in 2016.

Sumanth Gandra, Sanjeev K Singh, Dasaratha R Jinka, Ravishankar Kanithi, Ashok K Chikkappa, Anita Sharma, Dhanya Dharmapalan, Anil Kumar Vasudevan, Onkaraiah Tunga, Akhila Akula and 6 more

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. A systematic review of antimicrobial resistance of typhoidalThe Indian journal of medical research · 2019
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Point prevalence survey of antibiotics in a pediatric tertiary hospital in the Republic of Panama.Revista panamericana de salud publica = Pan American journal of public health · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 3 countries.

Sumanth GandraCenter for Disease Dynamics, Economics & Policy, New Delhi 110020, India. gandra@cddep.org.
Sanjeev K SinghDepartment of Infection Control & Microbiology, Amrita Institute of Medical Sciences, Amrita University, Ponekkara, Kochi 682041, India. sanjeevksingh@aims.amrita.edu.
Dasaratha R JinkaDepartment of Infectious Diseases & Department of Paediatrics, Rural Development Trust Hospital, Bathalapalli 515661, India. jdashrath86@gmail.com.
Ravishankar KanithiDepartment of Paediatrics, Sowmya Children's Hospital, Hyderabad 500038, India. ravineonatologist@gmail.com.
Ashok K ChikkappaDepartment of Paediatrics, Rural Development Trust Hospital, Kalyanadurgam 515761, India. ashokkld1971@yahoo.com.
Anita SharmaDepartment of Microbiology & Department of Paediatric Intensive Care Unit, Fortis Hospital, Mohali 160062, India. anita.sharma@fortishealthcare.com.
Dhanya DharmapalanDepartment of Paediatrics, Dr Yewale's Multispeciality Hospital for Children, Navi Mumbai 400703, India. drdhanyaroshan@gmail.com.
Anil Kumar VasudevanDepartment of Infection Control & Microbiology, Amrita Institute of Medical Sciences, Amrita University, Ponekkara, Kochi 682041, India. vanilkumar@aims.amrita.edu.
Onkaraiah TungaDepartment of Paediatrics, Rural Development Trust Hospital, Kalyanadurgam 515761, India. onkaraiahtunga@gmail.com.
Akhila AkulaDepartment of Paediatrics, Sowmya Children's Hospital, Hyderabad 500038, India. akhi0602@gmail.com.
Garima GargDepartment of Microbiology & Department of Paediatric Intensive Care Unit, Fortis Hospital, Mohali 160062, India. Garima.garg@fortishealthcare.com.
Yingfen HsiaPaediatric Infectious Diseases Research Group, Institute of Infection and Immunity, St. Georges University, London SW17 0RE, UK. yhsia@sgul.ac.uk.ORCID 0000-0002-7955-852X
Srinivas MurkiDepartment of Neonatology, Fernandez Hospital, Hyderabad 500029, India. srinivasmurki2001@gmail.com.
Gerardo Alvarez-UriaDepartment of Infectious Diseases & Department of Paediatrics, Rural Development Trust Hospital, Bathalapalli 515661, India. gerardouria@gmail.com.ORCID 0000-0003-1847-9614
Mike SharlandPaediatric Infectious Diseases Research Group, Institute of Infection and Immunity, St. Georges University, London SW17 0RE, UK. Mike.Sharland@stgeorges.nhs.uk.
Ramanan LaxminarayanCenter for Disease Dynamics, Economics & Policy, New Delhi 110020, India. ramanan@cddep.org.
Medical Trust Hospital · INAmrita Institute of Medical Sciences and Research Centre · INFortis Hospital · INRainbow Children's Hospital · INSt George's, University of London · GBAxis Multispecialty Hospital · INCenter for Disease Dynamics, Economics and Policy · INFernandez Hospital · INPrinceton University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence of antimicrobial resistance in India is among the highest in the world. Antimicrobial use in inpatient settings is an important driver of resistance, but is poorly characterized, particularly in hospitalized children. In this study, conducted as part of the Global Antimicrobial Resistance, Prescribing, and Efficacy in Neonates and Children (GARPEC) project, we examined the prevalence of and indications of antimicrobial use, as well as antimicrobial agents used among hospitalized children by conducting four point prevalence surveys in six hospitals between February 2016 and February 2017. A total of 681 children were hospitalized in six hospitals across all survey days, and 419 (61.5%) were prescribed one or more antimicrobials (antibacterials, antivirals, antifungals). Antibacterial agents accounted for 90.8% (547/602) of the total antimicrobial prescriptions, of which third-generation cephalosporins (3GCs) accounted for 38.9% (213/547) and penicillin plus enzyme inhibitor combinations accounted for 14.4% (79/547). Lower respiratory tract infection (LRTI) was the most common indication for prescribing antimicrobials (149 prescriptions; 24.8%). Although national guidelines recommend the use of penicillin and combinations as first-line agents for LRTI, 3GCs were the most commonly prescribed antibacterial agents (55/149 LRTI prescriptions; 36.9%). In conclusion, 61.5% of hospitalized children were on at least one antimicrobial agent, with excessive use of 3GCs. Hence there is an opportunity to limit their inappropriate use.

Indexed as

antimicrobial usechildrenhospitalIndiapoint prevalence survey

Identifiers

PMID28902135
PMCPMC5617983
OpenAlexW2755897447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.